Skip to main content
Elsevier

Progress in Molecular Biology and Translational Science

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B

  • 1st Edition, Volume 163 - April 26, 2019
  • Latest edition
  • Editor: Lijuan Zhang
  • Language: English

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informa… Read more

Description

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases—30 Years Clinical Applications in China, and more.

Key features

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field

Readership

Scientists working actively in these fields, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work

Table of contents

1. An Overview of Fugal Glycan-based Therapeutics
Dandan Yang

2. Heparin: An Essential Drug for Modern Medicine
Cui Hao

3. Low Molecular Weight Heparins and Their Clinical Applications
Cui Hao

4. The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharide
Yiran Zhang

5. Heparinoids as Clinically Used Drugs
Huaiqian Dou

6. Marine Glycan-Derived Therapeutics in China
Yanyun Gao

7. Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases--30 Years Clinical Applications in China
Ming Shan

8. Ganoderma Sinense Polysaccharide--An Adjunctive Drug Used for Cancer Treatment
Meng Zhang

9. Fucoidan Used for Treating Renal Diseases: A Review of 15 Years Clinical Studies
Jing Wang

10. Ganoderma Lucidum Polysaccharide Used for Treating Physical Frailty in China
Pengjiao Zeng

11. The Biological Activities of the Antitumor Drug Grifola Frondosa Polysaccharide
Yanli He

12. Molecular Basis for Poria cocos Mushroom Polysaccharide Used as an Antitumor Drug in China
Xiulian Li

13. Biological Mechanisms of Glycan- and Glycosaminoglycan-based Nutraceuticals
Yang Tang

14. Mushroom Polysaccharide Lentinan for Treating Different Types of Cancers—A Review of 12 Years Clinical Studies in China
Yiran Zhang

15. Polyporus Umbellatus Polysaccharide in Treating Hepatitis B in China
Zhihua Guo

16. Coriolus Versicolor Polysaccharopeptide as an Immunotherapeutic in China
Huaiqian Dou

17. Tremella Polysaccharide: The molecular Mechanisms of its Drug Action
Dandan Yang

18. The Structures and Biological Functions of Polysaccharides from Traditional Chinese Herbs
Pengjiao Zeng

Product details

  • Edition: 1
  • Latest edition
  • Volume: 163
  • Published: April 26, 2019
  • Language: English

About the editor

LZ

Lijuan Zhang

Lijuan Zhang is a Professor of Translational Medicine at Ocean University of China. She completed her doctorates of biochemistry and molecular genetics at University of Alabama at Birmingham in 1995. Before then, she was a Fogarty International Fellow at NIH for three years studying glycan-based cancer biomarkers. She worked as post-doctorate fellow and research associate at both MIT and Harvard Medical School from 1995-2002. She joined the faculty of the Department of Pathology & Immunology at Washington University in St. Louis in 2002 as a tenure-tracked Assistant Professor. Her research had been focused on the biosynthesis, structures, and biological functions of glycans since 1985. Now her work is on translational aspects of glycans as biomarkers and therapeutics. She has over 60 peer reviewed publications. She edited and published a book entitled “Glycosaminoglycans in Development, Health, and Diseases” with the contributions of top scientists worldwide in 2010 by Elsevier.
Affiliations and expertise
Ocean University of China, Qingdao, China

View book on ScienceDirect

Read Progress in Molecular Biology and Translational Science on ScienceDirect